Purpose: The aim of this study was to compare theefficiency of laparoscopic and transvaginal meshoperations with conservative surgery of reproductive-agewomen with pelvic organ prolapse (stage≥2) (POP).Materials and Methods: In this study, we retrospectivelyevaluated 22 cases of 105 patients who diagnosed withsymptomatic POP-Q stage 2 and above pelvic prolapse,part of whom underwent laparoscopic surgery (Group-1)while the other part composed of those who underwenttransvaginal mesh (TVM) surgery (Group-2). Urogenitalprolapse Pelvic Organ was graded using POP-Q.As thecurrent TVM surgical kits four-arms mesh was used.Results: The mean age of the patients of both groups was42.2±11.4 and 38.3±12.8 years, respectively. The meanduration of hospitalization for the patients underwentlaparoscopy was 2.3 days (range:1-4 days), that period wasobserved as 3 days in Group-2 (range:2-4 days). None ofour patients had any adverse reactions in the early or latestages. The rate of success was 95.45% for patients whounderwent laparoscopic surgery, while it was 98.10% forthe group of TVM surgery.Conclusion: Transvaginal mesh surgery was found to bea relatively successful technique in pelvic organ prolapsesurgery owing to the high rate of success and minimal ratesof complications.
|
Objective: To evaluate sacrococcygeal teratoma (SCT) cases according to associated cardiac, extracardiac, and chromosomal anomalies in the prenatal period, and to review their outcomes.Materials and Methods: Data of pregnancies with a prenatal diagnosis of SCT between 2009 and 2019 were retrospectively reviewed.Results: One ongoing pregnancy was excluded. There were five medically terminated cases, three due to severe heart failure and the remaining two due to additional congenital defects. Two infants who had heart failure due to hyperdynamic flow died in the neonatal period. Nine infants are well and alive at the time of writing.Conclusion: When a lesion is detected in the sacrococcygeal region during fetal sonography, the differential diagnosis should be made with an appropriate evaluation with emphasis on a possible diagnosis of fetal SCT. Tumor growth and heart failure should be monitored with serial scans when SCT has been diagnosed prenatally.
|
Mehmet ÖZSÜRMELİ , Selim BÜYÜKKURT, Mete SUCU, Erol ARSLAN, Çiğdem AKÇABAY, Selahattin MISIRLIOĞLU, Masum KAYAPINAR, Nazan ÖZBALAS, Süleyman Cansun DEMİR, İ. Cüneyt EVRÜKE
Objective: To evaluate persistent left superior vena cava (PLSVC) cases according to associated cardiac, extracardiac, and chromosomal anomalies in the prenatal period and to review their outcomes.Materials and Methods: The data of patients with a prenatal diagnosis of PLSVC between January 2013 and December 2017 were reviewed retrospectively.Results: Data of 32 cases were reviewed. Nineteen (60%) cases were associated with cardiac defects, 5 (15%) were associated with both cardiac and extracardiac defects, and 8 (25%) had no associated anomalies. Two fetuses had karyotype anomalies. All patients with isolated PLSVC survived. Among the cases associated with extracardiac anomalies, cardiac anomalies, and with both extracardiac and cardiac anomalies, the survival rate was 40%, 40%, and 25%, respectively. Outcome was more favorable in cases with isolated PLSVC (100% vs. 40%).Conclusion: Prenatally diagnosed PLSVC is associated with cardiac and extracardiac anomalies in the majority of cases. The prognosis is good in isolatedcases, but worsens when accompanied by cardiac or extracardiac anomalies.
|
